Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Chan

Showing results (111-120 of 195) with videos related to

Pageof 20
Sort By:
Biorxiv : the Preprint Server for Biology|July 14, 2025
High-Sensitive Spatial Proteomics for Pancreatic Cancer Progression AnalysisJongmin Woo, Zhenyu Sun, Yingwei Hu, et al.
Urology|December 15, 2004
Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%Masood A Khan, Lori J Sokoll, Daniel W Chan, et al.
Clinical Proteomics|January 25, 2019
Validation of a novel model for the early detection of hepatocellular carcinomaPhilip M Hemken, Lori J Sokoll, Xiaoqing Yang, et al.
Journal of Proteome Research|December 17, 2008
Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working groupMelissa K Tuck, Daniel W Chan, David Chia, et al.
The Journal of Urology|January 15, 2013
The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculatorDonna P Ankerst, Cathee Till, Andreas Boeck, et al.
Biometrical Journal. Biometrische Zeitschrift|November 19, 2011
Updating risk prediction tools: a case study in prostate cancerDonna P Ankerst, Tim Koniarski, Yuanyuan Liang, et al.
Clinical Chemistry|October 15, 2005
Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometryJinong Li, Rosaria Orlandi, C Nicole White, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 8, 2010
A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressivenessLori J Sokoll, Martin G Sanda, Ziding Feng, et al.
Urology|February 25, 2003
Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysisLori J Sokoll, Daniel W Chan, Stephen D Mikolajczyk, et al.
Cancer Research|March 26, 2002
Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technologyChristophe Rosty, Laurence Christa, Scott Kuzdzal, et al.
Pageof 20

Showing results (111-120 of 195) with videos related to

Sort By:
Pageof 20
Biorxiv : the Preprint Server for Biology|July 14, 2025
High-Sensitive Spatial Proteomics for Pancreatic Cancer Progression AnalysisJongmin Woo, Zhenyu Sun, Yingwei Hu, et al.
Urology|December 15, 2004
Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%Masood A Khan, Lori J Sokoll, Daniel W Chan, et al.
Clinical Proteomics|January 25, 2019
Validation of a novel model for the early detection of hepatocellular carcinomaPhilip M Hemken, Lori J Sokoll, Xiaoqing Yang, et al.
Journal of Proteome Research|December 17, 2008
Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working groupMelissa K Tuck, Daniel W Chan, David Chia, et al.
The Journal of Urology|January 15, 2013
The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculatorDonna P Ankerst, Cathee Till, Andreas Boeck, et al.
Biometrical Journal. Biometrische Zeitschrift|November 19, 2011
Updating risk prediction tools: a case study in prostate cancerDonna P Ankerst, Tim Koniarski, Yuanyuan Liang, et al.
Clinical Chemistry|October 15, 2005
Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometryJinong Li, Rosaria Orlandi, C Nicole White, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 8, 2010
A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressivenessLori J Sokoll, Martin G Sanda, Ziding Feng, et al.
Urology|February 25, 2003
Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysisLori J Sokoll, Daniel W Chan, Stephen D Mikolajczyk, et al.
Cancer Research|March 26, 2002
Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technologyChristophe Rosty, Laurence Christa, Scott Kuzdzal, et al.
Pageof 20